Literature DB >> 2407520

Identification and quantification of renin and prorenin in the bovine eye.

J Deinum1, F H Derkx, A H Danser, M A Schalekamp.   

Abstract

Angiotensin-II, the most important biologically active product of the renin-angiotensin system, has been reported to play a role in neovascularization, and prorenin has been found in the vitreous of human eyes, particularly in those affected by proliferative diabetic retinopathy, a disease characterized by neovascularization. The prorenin level in these eyes was, relative to that of plasma albumin, higher than in eyes without neovascularization. These findings suggested that an intraocular renin-angiotensin system exists, which might be involved in the development of retinal neovascularization in diabetes mellitus. In this study angiotensin-I-generating activity was measured in bovine aqueous humor and vitreous and in extracts of bovine retina, pigment epithelium-choroid, and anterior uveal tract before and after subjecting these extracts to procedures known to convert prorenin to renin. The measurements were made by incubation at 37 C with plasma from nephrectomized rats at pH ranging from 5.0-8.5. True renin in the ocular samples could be separated from nonrenin acid protease by alpha-casein-Sepharose affinity column chromatography at pH 3.5; true renin did not bind to the column, whereas acid protease did. True renin was further identified by its relatively high pH optimum (6.5-7.0) for angiotensin-I generation, its complete inhibition with specific renin antiserum, and its high affinity for specific renin inhibitors. More than 75% of angiotensin-I-generating activity of the ocular samples consisted of true renin. Approximately 90% or more of total renin (renin plus prorenin) in aqueous humor, vitreous, and ocular tissue could not be explained by trapped plasma. Total renin in aqueous humor and renin in vitreous were near the detection limit of the assay of angiotensin-I-generating activity. In vitreous prorenin comprised 99% of the total renin, in retina 81%, and in pigment epithelium-choroid and anterior uveal tract less than 50%. Prorenin in ocular fluids showed a concentration gradient, posterior vitreous greater than anterior vitreous greater than aqueous humor, suggesting that the main source of extracellular prorenin was in the posterior eye. These data support the contention of local renin and/or prorenin synthesis in the eye and are in accordance with the observations in other tissues that extrarenal synthesis of renin is often associated with the release of mainly, or exclusively, prorenin into extracellular fluid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2407520     DOI: 10.1210/endo-126-3-1673

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

Review 1.  Circulating versus tissue renin-angiotensin system: on the origin of (pro)renin.

Authors:  Manne Krop; A H Jan Danser
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

2.  The renin-angiotensin system in the human eye.

Authors:  N J Van Haeringen
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

3.  Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells.

Authors:  Amrisha Verma; Ping Zhu; Annette de Kloet; Eric Krause; Colin Sumners; Qiuhong Li
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

4.  ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy.

Authors:  Amrisha Verma; Zhiying Shan; Bo Lei; Lihui Yuan; Xuan Liu; Takahiko Nakagawa; Maria B Grant; Alfred S Lewin; William W Hauswirth; Mohan K Raizada; Qiuhong Li
Journal:  Mol Ther       Date:  2011-07-26       Impact factor: 11.454

5.  Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

Authors:  H Funatsu; H Yamashita; Y Nakanishi; S Hori
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

6.  Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM.

Authors:  S Mäkimattila; P Summanen; I Matinlauri; M Mäntysaari; A Schlenzka; M Aalto; K Irjala; H Yki-Järvinen
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

7.  Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system.

Authors:  J Wagner; A H Jan Danser; F H Derkx; T V de Jong; M Paul; J J Mullins; M A Schalekamp; D Ganten
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

8.  Current and future approaches in the prevention and treatment of diabetic retinopathy.

Authors:  Louis K Chang; David Sarraf
Journal:  Clin Ophthalmol       Date:  2008-06

9.  Mast cells: a unique source of renin.

Authors:  Randi B Silver; Alicia C Reid; Christina J Mackins; Trevor Askwith; Ulrich Schaefer; Doris Herzlinger; Roberto Levi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

Review 10.  Renin/prorenin-receptor biochemistry and functional significance.

Authors:  Geneviève Nguyen; Céline A Burcklé; Jean-Daniel Sraer
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.